Dynamics of Tumor-informed Circulating Tumor DNA and Association with Clinical Responses to Enfortumab and Pembrolizumab in Patients with Lo
. Vlachou, B.A. Johnson 3rd, M. Kates et al, Eur Urol Open Sci (2025)
Read Publication
Peer-reviewed Publications
Read our peer-reviewed publications and published data across cell-free DNA applications.
-
-
Signatera Peer-Reviewed Publications
View All -
Women's Health Peer-Reviewed Publications
View All -
Organ Health Peer-Reviewed Publications
View All -
Molecular Residual Disease and Recurrence in Rectal Cancer Patients Undergoing Upfront Surgery: A Prospective Cohort Study
Ando K, Hamabe A, Nakamura Y, et al. Ann Surg. 2026
Read Publication
-
Utility of Circulating Tumor DNA to Assess Tumor Response in Patients with Locally Advanced Rectal Cancer Undergoing Neoadjuvant Therapy
Chakrabarti S, et al. Cancers. 2026
Read Publication
-
Alteration of the Tumor Microenvironment With Intratumoral Dendritic Cells Before Chemotherapy in ERBB2 Breast Cancer A Nonrandomized Clinic
Han, H.S. et al; JAMA Oncology 2025
Read Publication
-
Adjuvant endocrine therapy with cyclindependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/ HER2– breast canc
Spring L. M. et al; npj Breast Cancer 2025
Read Publication
-
Personalized Circulating Tumor DNA Testing for Detection of Progression and Treatment Response Monitoring in Patients With Metastatic Invasi
Foldi J; JCO Precision Oncology 2025
Read Publication
-
Peri-operative atezolizumab in early-stage triple-negative breast cancer: final results and ctDNA analyses from the randomized phase 3 IMpas
Mittendorf E. A. et al; Nature Medicine 2025
Read Publication
-
Circulating Tumor DNA (ctDNA) is Reliably Detected in Patients with Metastatic Malignant Phyllodes Tumors, a Feasibility Study
Reason E. H. et al; Ann Surg Oncol 2025
Read Publication
-
Detection and Monitoring of Breast Cancer Local Recurrence Via Circulating Tumor DNA Minimal Residual Disease Assay
Prasath V, et al; JCO Precision Oncology 2025
Read Publication
-
Circulating tumor DNA refines risk stratification of neoadjuvant therapyresistant breast tumors
Magbanua M. J. et al; Nature Communications 2025
Read Publication
-
Exploring the utility of ctDNA testing in high-risk breast cancer patients in a community setting: case series
Wong K, et al; Ther Adv Med Oncol 2025
Read Publication
-
Donor-Derived Cell-Free DNA in Pancreas-Kidney, Heart-Kidney, and Liver-Kidney Multiorgan Transplant Recipients (MOTR)
Gupta, et al. Transplant International. 2026
Read Publication
-
Validation of a methylation-based, tissue-free MRD assay in colorectal cancer patients from the GALAXY study
Nakamura Y. Reiter J.G. Natarajan P. et al. npj Precis. Onc. 2026
Read Publication
-
Surveillance Donor-derived Cell-free DNA Allows for the Safe Reduction in Protocol Transbronchial Biopsies After Lung Transplantation
Kashika Goyal, et al. Transplantation Direct. 2026
Read Publication
-
Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib
Zhang et al. JAMA Oncology 2025
Read Publication
-
Circulating tumor DNA refines risk stratification of neoadjuvant therapy- resistant breast tumors
Mark Jesus M. Magbanua, et al. Nature Communications 2025
Read Publication
-
Genetic Testing in the Management of Adult CKD
Chebib, F; et al. Journal of the American Society of Nephrology 2025
Read Publication
-
ctDNA Monitoring in Ovarian Cancer Patients Receiving PARPi
Toboni, Michael D, et al. Gynecologic Oncology 204 (2026)
Read Publication
-
Neoadjuvant PD-1 and LAG-3-targeting bispecific antibody and other immune checkpoint inhibitor combinations in resectable melanoma the rando
Long, Georgina V, et al. Nature Medicine 2025
Read Publication
-
Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274
Galsky MD, Gschwend JE, Milowsky MI, et al. Ann Oncol. 2025
Read Publication
-
Loading More...
